Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | CAR T-cells: current climate & future perspectives in myeloma

Nico Gagelmann • 1 Sep 2020
EBMT 2020
Multiple Myeloma CAR-T

Nico Gagelmann, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, provides an outlook on the current CAR-T climate for multiple myeloma, and where things might move in the future, including longer follow up, new targets, as well as allogeneic CAR T-cell approaches. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Nico Gagelmann

5:03
Meta-analysis: anti-BCMA CAR-T in R/R myeloma
Nico Gagelmann • 1 Sep 2020

Related Videos

2:47
KarMMa-3 results: ide-cel vs standard regimens in triple-class exposed multiple myeloma
Sergio Giralt • 17 Feb 2023
1:05
Novel CAR-T constructs emerging for patients with multiple myeloma who experience loss of BCMA
Hermann Einsele • 10 Feb 2023
2:17
The importance of managing hematologic toxicity associated with CAR-T therapy
Marion Subklewe • 10 Feb 2023
2:45
Phase I study of CC-98633 in R/R multiple myeloma
Luciano Costa • 11 Dec 2022
The content of VJRegenMed is intended for healthcare professionals